สินทรัพย์ กรุงเทพพาณิชย์ จำกัด (มหาชน) 2567 สอบทาน Equity Method Statement ไตรมาสที่ 3 30/09/2567 บริษัทบริหารสินทรัพย์ กรุงเทพพาณิชย์ จำกัด (มหาชน) 2567 สอบทาน เดี่ยว ไตรมาสที่ 3 30/09/2567 บริษัทบริหาร
groups, namely: 1.1 Disclosure of information liable to causing damage to investors and capital market. This includes disseminating information or make a statement that is false or misleading in a
interest and taxes (EBIT) based on NEXT’s operating performance reported in the audited financial statements for the year ended December 31, 2 0 2 0 (the “Financial Statement”), and the amount shall not
Commission governing the maintenance of financial status of a licensed securities company; (2) shareholders’ equity as shown in the latest financial statement that has been audited by an auditor approved by
) shareholders’ equity as shown in the latest financial statement that has been audited by an auditor approved by the Office shall be positive. In case where the securities company increase its paid-up capital
governing the maintenance of financial status of a licensed derivatives broker; (2) shareholders’ equity as shown in the latest financial statement that has been audited by an auditor approved by the Office
of the Securities and Exchange Commission governing the maintenance of financial status of a licensed derivatives broker; (2) shareholders’ equity as shown in the latest financial statement that has
Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book